Sanara MedTech, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US79957L1008
USD
21.80
1.6 (7.92%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Sanara MedTech, Inc. stock-summary
stock-summary
Sanara MedTech, Inc.
Pharmaceuticals & Biotechnology
Sanara Medtech Inc., formerly Wound Management Technologies, Inc., formerly MB Software, Inc., distributes collagen-based wound care products to healthcare providers, such as physicians, clinics and hospitals. The Company's subsidiaries include Wound Care Innovations, LLC (WCI), Resorbable Orthopedic Products, LLC and Innovate OR, Inc. The Company's WCI provides CellerateRX product in the wound care market. CellerateRX is a medical device for use on all acute and chronic wounds, except third degree burns. CellerateRX is offered in both gel and powder form. WCI expanded its CellerateRX product line to include CellerateRX Surgical products.
Company Coordinates stock-summary
Company Details
1200 Summit Ave Ste 414 , FORT WORTH TX : 76102-4407
stock-summary
Tel: 1 817 5292300
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 18 Schemes (5.22%)

Foreign Institutions

Held by 15 Foreign Institutions (1.38%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Ronald Nixon
Executive Chairman of the Board
Mr. J Carmena
Principal Executive Officer, Director
Mr. Robert DeSutter
Director
Ms. Sara Ortwein
Director
Ms. Ann Salamone
Director
Dr. Kenneth Thorpe
Director
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
26 Million
(Quarterly Results - Jun 2025)
Net Profit:
-2 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 318 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.78

stock-summary
Return on Equity

-32.95%

stock-summary
Price to Book

8.99